Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1187952
Reference Type
Journal Article
Title
Preparation of N-demethylated drug metabolites for analytical purposes using 1-chloroethyl chloroformate
Author(s)
Pelander, A; Ojanpera, I; Hase, TA
Year
1997
Is Peer Reviewed?
Yes
Journal
Forensic Science International
ISSN:
0379-0738
EISSN:
1872-6283
Publisher
ELSEVIER SCI IRELAND LTD
Location
CLARE
Volume
85
Issue
3
Page Numbers
193-198
Language
English
DOI
10.1016/S0379-0738(96)02088-9
Web of Science Id
WOS:A1997WV91500003
URL
http://www.sciencedirect.com/science/article/pii/S0379073896020889
Exit
Abstract
Potential reagents for the N-demethylation of tertiary amines were screened in order to produce drug metabolite reference material for forensic toxicological applications, and 1-chloroethyl chloroformate was found to be the reagent of choice. The reaction was performed by refluxing in dry 1,2-dichloroethane under nitrogen, and the carbamate intermediate was hydrolysed by treatment with methanol. The products were purified by preparative layer chromatography, and their structures were confirmed by gas chromatography-mass spectrometry and by thin layer chromatography using derivatization with Fast Black K salt. The five drugs investigated, promazine, levomepromazine, orphenadrine, clomipramine and chlorprothixene, N-demethylated smoothly and the yields of the purified products were between 40 and 60% from 20 mg of the starting compound.
Keywords
demethylation; drug metabolite; 1-chloroethyl chloroformate
Tags
IRIS
•
Methanol (Non-Cancer)
Search 2012
WOS
Other
•
Harmful Algal Blooms- Health Effects
April 2021 Literature Search
WOS
Scopus
Saxitoxins
WOS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity